Viewing StudyNCT06201559



Ignite Creation Date: 2024-05-06 @ 7:58 PM
Last Modification Date: 2024-10-26 @ 3:17 PM
Study NCT ID: NCT06201559
Status: COMPLETED
Last Update Posted: 2024-01-11
First Post: 2023-12-30

Brief Title: Bioequivalence Study Between Two Albendazole 400 mg Tablets in Healthy Adult Participants Under Fed Conditions
Sponsor: GlaxoSmithKline
Organization: GlaxoSmithKline

Conditions & Keywords Data

Conditions:
Name
Intestinal Diseases
Keywords:
Name View
Bioequivalence View
Albendazole View